Targeting prostate cancer with HTI-286,
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin
✍
Boris A. Hadaschik; Susan Ettinger; Richard D. Sowery; Amina Zoubeidi; Raymond J
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
French
⚖ 602 KB
## Abstract Therapeutic resistance is the underlying cause for most cancer deaths and a major problem associated with treatment of metastatic prostate cancer. HTI‐286, a fully synthetic analog of the natural tripeptide hemiasterlin, inhibits tubulin polymerization and circumvents transport‐based re